Your browser is no longer supported. Please, upgrade your browser.
Settings
HSKA Heska Corporation daily Stock Chart
HSKA [NASD]
Heska Corporation
Index- P/E31.84 EPS (ttm)1.90 Insider Own2.40% Shs Outstand7.17M Perf Week-0.02%
Market Cap434.43M Forward P/E28.78 EPS next Y2.11 Insider Trans-9.35% Shs Float6.57M Perf Month-26.13%
Income14.50M PEG1.72 EPS next Q0.58 Inst Own89.80% Short Float5.93% Perf Quarter-30.92%
Sales135.70M P/S3.20 EPS this Y92.80% Inst Trans8.68% Short Ratio4.33 Perf Half Y-39.64%
Book/sh14.15 P/B4.28 EPS next Y4.00% ROA11.00% Target Price98.83 Perf Year-25.20%
Cash/sh1.03 P/C58.71 EPS next 5Y18.50% ROE15.30% 52W Range56.59 - 115.00 Perf YTD-24.46%
Dividend- P/FCF62.06 EPS past 5Y28.90% ROI13.90% 52W High-47.31% Beta0.89
Dividend %- Quick Ratio1.10 Sales past 5Y13.20% Gross Margin42.60% 52W Low7.07% ATR2.94
Employees327 Current Ratio2.30 Sales Q/Q-6.00% Oper. Margin12.90% RSI (14)30.63 Volatility3.88% 5.02%
OptionableNo Debt/Eq0.06 EPS Q/Q-10.50% Profit Margin10.70% Rel Volume0.52 Prev Close59.96
ShortableYes LT Debt/Eq0.00 EarningsFeb 28 BMO Payout0.00% Avg Volume89.85K Price60.59
Recom2.10 SMA20-10.82% SMA50-19.29% SMA200-32.88% Volume47,148 Change1.05%
Feb-05-18Upgrade Sidoti Neutral → Buy $94
Nov-03-17Reiterated B. Riley FBR, Inc. Neutral $96.50 → $93
Aug-03-17Reiterated The Benchmark Company Buy $106 → $120
Mar-01-17Reiterated The Benchmark Company Buy $100 → $106
Jan-26-17Downgrade CL King Buy → Neutral
Nov-29-16Initiated The Benchmark Company Buy $78
Aug-04-16Downgrade Gabelli & Co Buy → Hold
Jul-01-16Initiated Sidoti Buy
Apr-01-16Initiated CL King Buy
Dec-12-14Initiated Gabelli & Co Buy $20
Aug-08-13Reiterated Feltl & Co. Strong Buy $12.50 → $9.50
Sep-11-12Initiated Feltl & Co. Strong Buy $13.50
Aug-13-12Downgrade C.K. Cooper Buy → Hold
Jun-08-12Initiated C.K. Cooper Buy $20
Feb-09-18 08:00AM  Heska Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for February 28, 2018 PR Newswire
Jan-30-18 07:30AM  Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-01-17 04:05PM  Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure PR Newswire
Nov-27-17 02:09PM  ETFs with exposure to Heska Corp. : November 27, 2017 Capital Cube
Nov-21-17 12:33PM  Mariko Gordon Starts 5 New Positions in 3rd Quarter GuruFocus.com
Nov-06-17 06:16PM  Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT Thomson Reuters StreetEvents
01:07PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : November 6, 2017 Capital Cube
Nov-03-17 08:34AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017 Capital Cube +6.09%
Nov-02-17 08:25AM  Heska beats 3Q profit forecasts Associated Press -15.74%
08:00AM  Heska Reports Third Quarter Results PR Newswire
Nov-01-17 08:00AM  Heska Announces 7-Year Agreement with PetVetCare Centers PR Newswire
Oct-31-17 08:00AM  Heska extends product line with new Element COAG Veterinary Analyzer PR Newswire
Oct-30-17 11:57AM  ETFs with exposure to Heska Corp. : October 30, 2017 Capital Cube
Oct-12-17 08:00AM  Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017 PR Newswire
Oct-09-17 11:38AM  ETFs with exposure to Heska Corp. : October 9, 2017 Capital Cube
08:41AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017 Capital Cube
Oct-06-17 09:04AM  Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-18-17 10:01AM  TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion Zacks
Sep-15-17 11:22AM  The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton Zacks
Sep-14-17 05:39PM  4 Biotech Stocks That Show Promise on Sustainable Growth Zacks
09:33AM  Obama-Trump Bull Run is the Second Best Ever: Top 5 Gainers Zacks
Aug-28-17 11:01AM  Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR Zacks
Aug-25-17 10:43AM  5 Efficient Stocks to Buy for a Healthy Portfolio Zacks
Aug-24-17 08:26AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017 Capital Cube
Aug-23-17 04:11PM  Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT Thomson Reuters StreetEvents
08:00AM  Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017 PR Newswire
Aug-16-17 09:16PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : August 17, 2017 Capital Cube
Aug-04-17 09:50AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017 Capital Cube
Jul-31-17 11:02PM  Heska posts 2Q profit Associated Press
08:00AM  Heska Reports Second Quarter Results PR Newswire
06:45AM  Investor Network: HESKA CORP to Host Earnings Call ACCESSWIRE
Jul-27-17 07:34PM  Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase PR Newswire
Jul-20-17 04:05PM  Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10 PR Newswire
Jul-11-17 02:38PM  ETFs with exposure to Heska Corp. : July 11, 2017 Capital Cube
08:00AM  Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017 PR Newswire
Jun-30-17 03:02PM  ETFs with exposure to Heska Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:09AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : June 22, 2017 Capital Cube
Jun-19-17 03:29PM  ETFs with exposure to Heska Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Heska Corp. :HSKA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-13-17 09:00AM  Scott Humphrey Joins Heska's Board of Directors PR Newswire
Jun-08-17 02:05PM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:46AM  Why Heska (HSKA) Could Be Positioned for a Surge Zacks
May-26-17 08:27AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 26, 2017 Capital Cube
May-04-17 04:51PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : May 4, 2017 Capital Cube
08:00AM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-03-17 08:46AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 3, 2017 Capital Cube -5.00%
May-02-17 12:33PM  Here's Why Heska Corporation Is Dropping Today Motley Fool -14.21%
08:15AM  Heska posts 1Q profit Associated Press
08:05AM  Investor Network: Heska Corporation to Host Earnings Call Accesswire
08:00AM  Heska Reports First Quarter Results PR Newswire
May-01-17 09:59AM  Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2 Zacks
Apr-28-17 10:43AM  Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up Zacks
09:57AM  Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates Zacks
09:31AM  Align Technology (ALGN) Beats on Q1 Earnings and Revenues Zacks
Apr-27-17 09:03AM  Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1 Zacks
08:00AM  Heska To Present at Four Upcoming Conferences PR Newswire
Apr-26-17 11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
Apr-25-17 05:19PM  Reminder: Heska Annual Meeting of Stockholders on May 1, 2017 PR Newswire
Apr-20-17 06:07PM  CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Zacks
09:30AM  Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne Zacks
Apr-19-17 10:38AM  Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III Zacks
07:42AM  Create an Efficient Portfolio with 5 Top Stocks Zacks
Apr-18-17 10:08AM  Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Zacks
09:29AM  Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug Zacks
Apr-17-17 09:47AM  Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. Zacks
Apr-13-17 08:58AM  Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe Zacks
08:00AM  Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017 PR Newswire
Apr-12-17 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 1, 2017 PR Newswire
Apr-10-17 05:27PM  Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion Zacks
05:18PM  Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint Zacks
Apr-06-17 09:57AM  Bristol-Myers' (BMY) sBLA For Opdivo Accepted by the FDA Zacks
Apr-05-17 08:35PM  Today's Strong Buy Stocks at New Highs Zacks
03:36PM  Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst Zacks
12:48PM  Roche Announces Positive Data on Lung Cancer Drug Alecensa Zacks
09:10AM  Amedisys (AMED) Poised on Strong Home Health, Risks Remain Zacks
Apr-04-17 12:01PM  Bristol-Myers Announces Data on Immuno-oncology Drug Opdivo Zacks
11:12AM  QIAGEN Releases Favorable GeneReader Results, Expands in NGS Zacks
09:30AM  Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources Zacks
Apr-03-17 09:17AM  BioDelivery to Grant New Patents for its Marketed Drugs Zacks
08:20AM  5 Stocks with Solid Efficiency Ratio to Buy in April Zacks
Mar-30-17 02:11PM  Roche's Rituxan Gets FDA Advisory Committee's Recommendation +7.30%
02:11PM  Roche's Rituxan Gets FDA Advisory Committee's Recommendation Investopedia
12:35PM  Bill Ackman Apologizes for Valeant Investment Error at Investopedia
11:30AM  Acorda Presents Data for Parkinson's Candidate CVT-301 at Investopedia
09:46AM  Amgen's Leukemia Drug Accepted for Priority Review by FDA at Investopedia
Mar-29-17 06:21PM  Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600 PR Newswire
05:43PM  Roche's Ocrevus Wins FDA Approval for 2 Forms of Sclerosis
05:18PM  Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage at Investopedia
04:51PM  Corcept (CORT) Strives to Commercialize Key Drug Korlym
10:45AM  Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III
10:34AM  Orexigen Posts Wider-than-Expected Loss in Q4; Sales Up Y/Y
10:21AM  Regeneron & Sanofi's Atopic Dermatitis Drug Gets FDA Nod
Mar-28-17 06:03PM  Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017?
Mar-27-17 08:39AM  Why Heska Corporation (HSKA) Could Be an Impressive Growth Stock
Mar-23-17 05:03PM  Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
10:16AM  Alexion (ALXN) Files for Soliris' Label Expansion in Japan
08:15AM  XBiotech (XBIT) Catches Eye: Stock Moves Up 11.6% in Session
Mar-21-17 04:32PM  Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA
04:22PM  Mylan Receives Tentative Approval from FDA for HIV Therapy
Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. It operates through two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the preventive treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels. The Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Dec 28Option Exercise18.3011,000201,30043,119Dec 29 04:43 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Dec 13Option Exercise18.307,000128,10045,128Dec 15 01:57 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 30Sale86.026,500559,12492,446Dec 04 02:40 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 29Sale87.027,025611,28298,946Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 28Sale88.1980070,549105,971Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 27Sale88.54189106,771Nov 29 06:16 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Aug 31Sale102.2182584,32738,114Aug 31 05:28 PM
McMahon JohnVP, Chief Financial OfficerAug 30Option Exercise63.322,608165,1442,676Aug 31 05:26 PM
McMahon JohnVP, Chief Financial OfficerAug 30Sale101.172,608263,85768Aug 31 05:26 PM
Asakowicz SteveEVP, Comp. Animal Health SalesJun 01Option Exercise18.133826,92610,382Jun 01 05:10 PM
Asakowicz SteveEVP, Comp. Animal Health SalesJun 01Sale100.0838238,23110,000Jun 01 05:10 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 31Option Exercise46.794,471209,20212,709May 31 02:04 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 31Sale98.004,471438,1589,814May 31 02:04 PM
McGinley Michael JPresi, Biologic. & Pharm.May 31Sale98.5311,1891,102,434106,747Jun 01 05:08 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 26Option Exercise13.326,75690,01612,628May 31 02:04 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 26Sale98.006,756662,1119,814May 31 02:04 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 24Sale100.1725025,04238,901May 25 04:49 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 24Sale100.505,000502,50032,119May 26 12:51 PM
WRENN CAROLDirectorMay 23Option Exercise8.101,63013,2036,174May 25 04:46 PM
McMahon JohnVP, Chief Financial OfficerMay 23Option Exercise36.3541715,159462May 25 04:48 PM
WRENN CAROLDirectorMay 23Sale96.951,630158,0244,544May 25 04:46 PM
McMahon JohnVP, Chief Financial OfficerMay 23Sale97.0058756,9400May 25 04:48 PM
Larson Sharon J.DirectorMay 04Buy90.001,00090,0003,294May 05 11:25 AM
GORDON G IRWINDirectorMay 01Option Exercise12.9219,016245,66033,073May 02 05:44 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 11Sale100.7320020,14637,119Apr 12 01:23 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 10Sale103.4990093,13737,319Apr 12 01:23 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 10Sale102.943,900401,48238,219Apr 12 01:17 PM
Lippincott RodEVP, Comp. Animal Health SalesMar 09Option Exercise10.105,15752,07813,025Mar 09 02:08 PM
McMahon JohnVP, Chief Financial OfficerMar 09Option Exercise37.7570826,729658Mar 09 02:11 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Mar 09Sale96.6450048,32139,151Mar 10 01:15 PM
McMahon JohnVP, Chief Financial OfficerMar 09Sale97.4270868,97375Mar 09 02:11 PM
Lippincott RodEVP, Comp. Animal Health SalesMar 09Sale97.875,157504,7219,814Mar 09 02:08 PM
Wilson Kevin S.CEO and PresidentMar 06Sale90.008,000720,0006,432Mar 06 05:13 PM
Eyl Steven M.EVP, Global Sales & MarketingMar 02Option Exercise7.3610,00073,60021,271Mar 06 05:12 PM
Eyl Steven M.EVP, Global Sales & MarketingMar 02Sale89.2610,000892,55411,271Mar 06 05:12 PM